Benabou Reina 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 23, 2020
Insider Transaction Report
Form 4
Benabou Reina
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2020-06-22+60,000→ 60,000 totalExercise: $56.97Exp: 2030-06-21→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of June 22, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.